CLOROTEKAL
Total Payments
$10,441
Transactions
10
Doctors
2
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $4,749 | 4 | 1 |
| 2018 | $5,692 | 6 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,925 | 1 | 47.2% |
| Travel and Lodging | $4,211 | 3 | 40.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,225 | 1 | 11.7% |
| Food and Beverage | $80.82 | 5 | 0.8% |
Ad
Manufacturing Companies
- B. Braun Medical Inc. $5,692
- B. Braun Melsungen AG $4,749
Product Information
- Type Drug
- Total Payments $10,441
- Total Doctors 2
- Transactions 10
About CLOROTEKAL
CLOROTEKAL is a drug associated with $10,441 in payments to 2 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is B. Braun Medical Inc..
Payment data is available from 2018 to 2019. In 2019, $4,749 was paid across 4 transactions to 1 doctors.
The most common payment nature for CLOROTEKAL is "Consulting Fee" ($4,925, 47.2% of total).